What is CYP1A2?
The CYP1A2 gene is responsible for producing an enzyme that plays a crucial role in the metabolism of several important medications, including antipsychotics and antidepressants. A unique characteristic of CYP1A2 is that its activity is not only genetically determined but can also be strongly influenced by external factors such as diet and smoking. However, your genetic foundation (your genotype) forms the baseline upon which these factors act and determines how your body responds to specific substances.
The gene determines whether your body breaks down medication at the intended rate. If this pace deviates, it has direct consequences for the effectiveness of your treatment and the risk of unwanted side effects.
Why test your CYP1A2 status?
Understanding your CYP1A2 profile is essential to prevent a standard dosage from leading to unpredictable results:
- Risk of side effects: When the breakdown of medication is delayed, the concentration of the active substance in your bloodstream rises. This can lead to increased toxicity and severe side effects, even at a dose that is considered ‘normal’ for others.
- Insufficient levels: With an overactive enzyme (ultrarapid), your body breaks down the medication so quickly that a sufficiently high level in the blood is never reached to be effective. This can lead to the absence of the desired therapeutic effect.
- Lifestyle interactions: Since CYP1A2 is also involved in processing substances like caffeine and compounds in tobacco smoke, a DNA test helps explain why you might react more strongly to these substances or why medication dosages may need adjustment following lifestyle changes.
Medications where CYP1A2 plays a role
The following medication groups are primarily processed via the CYP1A2 pathway. A pharmacogenetic passport provides essential guidance for:
- Antipsychotics: e.g., Clozapine, Olanzapine, and Haloperidol.
- Antidepressants: e.g., Duloxetine, Clomipramine, and Fluvoxamine.
- Painkillers: e.g., Paracetamol (at very high dosages) and Naproxen.
- Muscle relaxants: e.g., Tizanidine.
- Other substances: e.g., Theophylline (for asthma) and Caffeine.
Interpretation of your CYP1A2 status
Your genetic result is classified into different metabolism types. This determines how your body responds to the medications mentioned above:
| Result | Interpretatie | Interpretation |
|---|---|---|
| PM | Poor Metabolizer (Non-expressor) | The enzyme is inactive. This is the case for most Europeans. You have an increased risk of side effects with standard doses of specific medications. |
| IM | Intermediate Metabolizer | The enzyme exhibits limited activity. Medication processing is slower than average, often requiring careful dosing. |
| NM | Normal Metabolizer (Expressor) | The enzyme is active and functioning normally. Certain medications (such as tacrolimus) are broken down more quickly, so a higher dose is often required for effectiveness. |
| UM | Ultrarapid Metabolizer | The enzyme works extremely quickly. Medication is removed from the body very quickly, which increases the risk of insufficient effectiveness of the therapy. |
Medical interpretation & advice
Your test results from Easly are cross-referenced with the official medication guidelines of the KNMP (G-Standard). This provides you, your pharmacist, and your doctor with a scientific foundation for a personalized treatment plan.
Important: Always use this result in consultation with your treating physician or pharmacist. Never adjust your dosage independently. Based on your profile, a doctor or pharmacist may decide to optimize the dose or switch to a medication that does not depend on this specific enzyme.
Don’t keep struggling with unexplained side effects.
Do you want to know if your symptoms can be explained by your DNA profile? Take the free Pharmacogenetic Quickscan (Only available in Dutch) and get immediate clarity on whether a test is right for you.
